Baird Financial Group’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.5M | Sell |
61,681
-49,111
| -44% | -$1.99M | ﹤0.01% | 938 |
|
|
2025
Q1 | $5.69M | Sell |
110,792
-31,627
| -22% | -$1.62M | 0.01% | 646 |
|
|
2024
Q4 | $7.89M | Sell |
142,419
-4,017
| -3% | -$222K | 0.02% | 569 |
|
|
2024
Q3 | $4.82M | Buy |
146,436
+22,658
| +18% | +$745K | 0.01% | 679 |
|
|
2024
Q2 | $3.36M | Sell |
123,778
-4,494
| -4% | -$122K | 0.01% | 792 |
|
|
2024
Q1 | $4.66M | Buy |
+128,272
| New | +$4.66M | 0.01% | 681 |
|